Stock & Company Details
PTC Therapeutics Inc $PTCT
Price:
46,691,331
83M
$6.1B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-4.51
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
PTCT technical indicators
Latest PTC Therapeutics Inc (PTCT) indicator readings as of 2026-08-10.
PTCT's 14-day RSI is 48.2, in neutral territory. At $74.63 it is trading 1.9% above its 200-day moving average of $73.23, and below its 50-day average of $77.27. Price sits in the middle of its Bollinger Bands ($67.40 to $82.46). ADX reads 23.5, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Finance Bot
Ask your questions
Start by typing a question below.
